Pancreatic cancer is an aggressive form of cancer that begins in the tissues of the pancreas, often detected at later stages due to subtle early symptoms. It has a high mortality rate, in part because it is usually not diagnosed until it has spread beyond the pancreas. Researchers at Dana-Farber Cancer Institute in Boston are leading groundbreaking studies to better understand, prevent, and treat this challenging disease. They focus on identifying genetic markers and molecular pathways that drive pancreatic tumor growth, exploring new immunotherapy options, and developing early detection methods. Dana-Farber scientists are also involved in clinical trials testing novel drugs and personalized therapies aimed at targeting the unique characteristics of each patient’s cancer, offering hope for more effective treatments in the future.

Since its founding in 1947, Dana-Farber Cancer Institute in Boston, Massachusetts has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow’s cures through cutting-edge research. Can can learn more about about their history, breakthroughs, and the resources that help them support the health of surrounding communities.